Norman Sussman - Oct 14, 2024 Form 4 Insider Report for DURECT CORP (DRRX)

Role
Chief Medical Officer
Signature
/s/ Norman Sussman
Stock symbol
DRRX
Transactions as of
Oct 14, 2024
Transactions value $
$0
Form type
4
Date filed
10/16/2024, 04:47 PM
Previous filing
Feb 23, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DRRX Stock Option (right to buy) Award $0 +104K $0.00 104K Oct 14, 2024 Common Stock 104K $1.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest and become exercisable in installments of one-sixteenth (1/16) of the total number of shares at the end of each three-month period following the grant date, subject to the Reporting Person providing continuous service to the Issuer through the applicable vesting date.